News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Krishnan Rajesh
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/04/2023 |
4
| Krishnan Rajesh (Chief Technical Officer) has filed a Form 4 on Oncternal Therapeutics, Inc.
Txns:
| Disposed/sold 75,000 options
@ $4.3, valued at
$322.5k
Disposed/sold 40,000 options
@ $5.76, valued at
$230.4k
Disposed/sold 12,470 options
@ $3.33, valued at
$41.5k
Disposed/sold 160,000 options
@ $4.59, valued at
$734.4k
Disposed/sold 177,050 options
@ $1.94, valued at
$343.5k
Disposed/sold 28,750 options
@ $1.04, valued at
$29.9k
Disposed/sold 220,000 options
@ $0.96, valued at
$211.2k
Granted 75,000 options
@ $0 Granted 40,000 options
@ $0 Granted 12,470 options
@ $0 Granted 160,000 options
@ $0 |
|
07/05/2023 |
4
| Krishnan Rajesh (Chief Technology Officer) has filed a Form 4 on Oncternal Therapeutics, Inc.
Txns:
| Paid exercise price by delivering 10,897 shares
@ $0.36, valued at
$3.9k
|
|
02/23/2023 |
4
| Krishnan Rajesh (Chief Technology Officer) has filed a Form 4 on Oncternal Therapeutics, Inc.
Txns:
| Granted 220,000 options
@ $0.96, valued at
$211.2k
|
|
01/05/2023 |
4
| Krishnan Rajesh (Chief Technology Officer) has filed a Form 4 on Oncternal Therapeutics, Inc.
Txns:
| Paid exercise price by delivering 6,238 shares
@ $1.02, valued at
$6.4k
|
|
08/01/2022 |
4
| Krishnan Rajesh (Chief Technology Officer) has filed a Form 4 on Oncternal Therapeutics, Inc.
Txns:
| Granted 43,125 shares
@ $0 Granted 28,750 options
@ $1.04, valued at
$29.9k
|
|
01/24/2022 |
4
| Krishnan Rajesh (Chief Technology Officer) has filed a Form 4 on Oncternal Therapeutics, Inc.
Txns:
| Granted 177,050 options
@ $1.94, valued at
$343.5k
|
|
01/05/2022 |
4
| Krishnan Rajesh (Chief Technology Officer) has filed a Form 4 on Oncternal Therapeutics, Inc.
Txns:
| Granted 29,867 shares
@ $0 |
|
05/27/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|